What to Know About the ‘Reta’ Injection Trending Online
NewBeauty Facebook Pinterest Instagram Youtube find a doctor Face Adult Acne Antioxidants Anti-Aging Celebrity Chronic Skin Conditions Eye Hydration Hyperpigmentation Makeup View All Eyebrows Eye Color Foundation Fragrance Lip Color Makeovers Male Skin Care Peels Pre-Event Prep Sensitive Skin Skin Care Skin Health Smile Sun Care Treatments Fillers Microneedling Post-Procedure Skin Care Neurotoxins Regenerative Aesthetics Skin Lifting Body Body Sculpting Breasts Butts Cellulite Hair Removal Hands + Nails Legs Pregnancy Find a Doctor Hair Bond Repair Celebrity Dry Hair Frizzy Hair Gray Hair Hair Color Hair Growth Hair Repair Scalp Health Styling + Tips Awards NB100 Awards 15th Annual Beauty Awards 2025 NewBeauty Readers’ Choice Awards Shopping Gift Guides Product Reviews NewBeauty Storefront Wellness Fitness GLP-1s Health Menopause About Us TESTTUBE Search for: Search HomeWellnessGLP-1s What to Know About the ‘Reta’ Injection Trending Online And why it’s raising red flags. Tatiana Bido Published: Dec 15, 2025 Tanja Ivanova/ Getty Images In This Article Featured ExpertsWhat Is Retatrutide?Why It’s TrendingWhy Doctors Are ConcernedWhy It’s Not Intended for Recreational Use If you’ve spent any time in fitness or weight-loss corners of social media lately, chances are you’ve seen the term “reta” pop up. Sometimes it’s tucked into a caption about leaning out; other times, it appears casually in comment threads alongside gym selfies and dramatic before-and-after photos. To the untrained eye, retatrutide can start to look like the next GLP-1 alternative already circulating in real life. But behind the buzz is a very different reality. Retatrutide is not FDA-approved. It is not commercially available. And while obesity medicine specialists have been watching its development closely for years, many are increasingly uneasy about how casually it’s being discussed—and, in some cases, used. Retatrutide is an investigational weight-loss medication from Eli Lilly and is widely viewed as the next generation of GLP-1 therapies, following…